Market Place
Sourcing Support
Taro`s Generic Diclofenac Potassium Receives Approval in US
14 Jun 2024 //
FDA
Taro Pharma`s Generic Diclofenac Potassium Receives Approval in the U.S
14 Jun 2024 //
FDA
Alkem Lab Generic Diclofenac Potassium Receives Approval in the U.S.
20 Jul 2022 //
FDA
Umedica Lab`s Generic Diclofenac PotassiumReceives Approval In US
11 May 2022 //
FDA
Annora Pharma`s Generic Diclofenac Potassium Receives Approval in the U.S.
04 Mar 2022 //
FDA
Aurobindo Pharma`s Generic Vigabatrin Receives Approval In US
23 Oct 2021 //
FDA
RiconPharma`s Generic Diclofenac Potassium Receives Approval in US
14 Oct 2021 //
FDA
NPPA directs Novartis to continue production of pain reliever Voltaflam 50 mg
18 Sep 2021 //
PHARMABIZ
Strides Pharma gets tentative nod from USFDA for pain relieving drug
04 Dec 2019 //
THE ECONOMIC TIMES
Strides Pharma`s Generic Diclofenac Potassium Receives Approval in US
03 Dec 2019 //
FDA
Mundipharma, Novartis to distribute pain medicine in SE Asia
12 Sep 2018 //
BIOSPECTRUM
Depomed Issues Statement on Horizon Pharma plc`s Unsolicited Exchange Offer
08 Sep 2015 //
PR NEWS WIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.